Davidson & Garrard’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$10.1M Sell
53,394
-2,653
-5% -$480K 2.38% 2
2017
Q2
$9.78M Sell
56,047
-1,911
-3% -$321K 2.33% 2
2017
Q1
$8.9M Sell
57,958
-904
-2% -$138K 2.12% 6
2016
Q4
$8.3M Sell
58,862
-1,110
-2% -$164K 2.06% 7
2016
Q3
$9.54M Sell
59,972
-1,375
-2% -$212K 2.37% 5
2016
Q2
$9.06M Sell
61,347
-1,180
-2% -$174K 2.23% 7
2016
Q1
$8.85M Sell
62,527
-795
-1% -$107K 2.27% 6
2015
Q4
$8.98M Buy
63,322
+2,648
+4% +$353K 2.23% 5
2015
Q3
$7.42M Buy
60,674
+259
+0.4% +$33.7K 1.92% 6
2015
Q2
$7.84M Sell
60,415
-446
-0.7% -$58.1K 1.82% 6
2015
Q1
$8.18M Sell
60,861
-426
-0.7% -$54.9K 1.86% 6
2014
Q4
$7.68M Buy
61,287
+3,222
+6% +$392K 1.78% 8
2014
Q3
$7.07M Sell
58,065
-1,399
-2% -$170K 1.72% 8
2014
Q2
$7.02M Sell
59,464
-1,787
-3% -$210K 1.68% 8
2014
Q1
$7.37M Sell
61,251
-2,729
-4% -$324K 1.83% 8
2013
Q4
$7.12M Sell
63,980
-925
-1% -$92K 1.81% 8
2013
Q3
$5.98M Sell
64,905
-2,598
-4% -$235K 1.68% 11
2013
Q2
$5.71M Buy
+67,503
New +$5.62M 1.7% 12

Other funds holding TMO

Davidson & Garrard's TMO Position: Q3 2017 in Review

Davidson & Garrard reduced its Thermo Fisher Scientific (TMO) stake by 4.7% in Q3 2017, selling an estimated $480K and leaving 53,394 shares worth $10.1M. The position accounts for 2.38% of the portfolio, ranked #2.

Davidson & Garrard first reported a position in TMO in Q2 2013 and has held it in 18 quarters since. 1,162 funds tracked by Wall St. Rank hold TMO as of Q3 2017.

  • Davidson & Garrard held 53,394 shares of Thermo Fisher Scientific worth $10.1M as of Q3 2017.
  • Davidson & Garrard sold 2,653 Thermo Fisher Scientific shares in Q3 2017, an estimated $480K.
  • Thermo Fisher Scientific made up 2.38% of Davidson & Garrard's portfolio in Q3 2017, its #2 holding.
  • Davidson & Garrard first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 18 quarters since.
  • 1,162 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2017.

Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.